UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 211

Sortiert nach

Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis"

Digestive and liver disease, 2022-08, Vol.54 (8), p.1133-1134

2022

Volltextzugriff (PDF)

Direct oral anticoagulants for portal vein thrombosis in cirrhosis: Good news from meta-analysis?

Digestive and liver disease, 2022-01, Vol.54 (1), p.54-55

2022

Volltextzugriff (PDF)

Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Digestive and liver disease, 2021-11, Vol.53 (11), p.1394-1395

2021

Volltextzugriff (PDF)

Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start?

Digestive and liver disease, 2021-10, Vol.53 (10), p.1364-1365

2021

Volltextzugriff (PDF)

Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)

Digestive and liver disease, 2022-11, Vol.54 (11), p.1520-1526

2022

Volltextzugriff (PDF)

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction: a case-control study

Journal of hepatology, 2017, Vol.66 (1), p.S180-S180

2017

Volltextzugriff (PDF)

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction(EHPVO). A case–control study

Digestive and liver disease, 2017-02, Vol.49 (1), p.e30-e30

2017

Volltextzugriff (PDF)

Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S584-S585

2017

Volltextzugriff (PDF)

Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S290-S291

2016

Volltextzugriff (PDF)

Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria

Digestive and liver disease, 2017-02, Vol.49 (1), p.e38-e38

2017

Volltextzugriff (PDF)

Screening and surveillance of esophageal varices: Validation of Baveno VI criteria in a cohort of cirrhotic HCV patients

Digestive and liver disease, 2016-02, Vol.48, p.e17-e17

2016

Volltextzugriff (PDF)

Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis

Digestive and liver disease, 2017-02, Vol.49 (1), p.e34-e34

2017

Volltextzugriff (PDF)

P0206 : Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Journal of hepatology, 2015-04, Vol.62, p.S383-S383

2015

Volltextzugriff (PDF)

Increased plasma levels of Von Willebrand factor (VWF) and Factor VIII (FVIII) during acute bacterial infection drive a pro-hemostatic imbalance and herald severe outcome in cirrhosis

Digestive and liver disease, 2016-02, Vol.48, p.e13-e13

2016

Volltextzugriff (PDF)

Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Digestive and liver disease, 2015-02, Vol.47, p.e10-e10

2015

Volltextzugriff (PDF)

Safety and Effectiveness of anticoagulation in patients with cirrhosis listed for liver transplantation: a single center observational study

Digestive and liver disease, 2024-02, Vol.56, p.S68-S69

2024

Volltextzugriff (PDF)

Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: really needed also in patients with HCV cured or HBV suppressed viral cirrhosis?

Journal of hepatology, 2023-03

2023

Volltextzugriff (PDF)

P.1.235: SERUM OSTEOPROTEGERIN IS DECREASED BY ANTI-TNF TREATMENT AND CORRELATES TO C-REACTIVE PROTEIN LEVELS

Digestive and liver disease, 2011, Vol.43, p.S226-S226

2011

Volltextzugriff (PDF)

Risk factors for post-banding ulcer bleeding in cirrhotic patients undergoing elective esophageal varices band ligation

Digestive and liver disease, 2021-03, Vol.53, p.S42-S42

2021

Volltextzugriff (PDF)

Preprocedural prophylaxis with blood products in patients with cirrhosis: results from a survey of the Italian Association for the study of the Liver (AISF)

Digestive and liver disease, 2022-03, Vol.54, p.S34

2022

Volltextzugriff (PDF)

THU-289 - Incidence and outcome of portal vein thrombosis in HCV cirrhotic patients treated with direct-acting antivirals: a single-center prospective 3-year study

Journal of hepatology, 2018-04, Vol.68, p.S258-S259

2018

Volltextzugriff (PDF)

Incidence and outcome of portal vein thrombosis in HCV cirrhotic patients treated with direct-acting antivirals: a single-center prospective 3-year study

Journal of hepatology, 2018-04, Vol.68, p.S258-S259

2018

Volltextzugriff (PDF)

FRI-350 - The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Journal of hepatology, 2018-04, Vol.68, p.S521-S521

2018

Volltextzugriff (PDF)

The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Journal of hepatology, 2018-04, Vol.68, p.S521

2018

Volltextzugriff (PDF)

Incidence of liver-related events in 647 HCV cirrhotics treated with DAA: A 5-year single center study

Digestive and liver disease, 2021-03, Vol.53, p.S15-S15

2021

Volltextzugriff (PDF)

1 – 25 von 211

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(98)
Humans
(95)
Female
(57)
Male
(57)
Biological And Medical Sciences
(46)
Adult
(40)
Medical Sciences
(37)
Middle Aged
(35)
Neurosciences & Neurology
(28)
Aged
(24)
Gastroenterology & Hepatology
(24)
Magnetic Resonance Imaging
(21)
Child
(18)
Clinical Neurology
(18)
Adolescent
(16)
Radiology, Nuclear Medicine & Medical Imaging
(15)
Neurosciences
(14)
Gastroenterology And Hepatology
(13)
Neuroimaging
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis"

Direct oral anticoagulants for portal vein thrombosis in cirrhosis: Good news from meta-analysis?

Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start?

Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction: a case-control study

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction(EHPVO). A case–control study

Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis

Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis

Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria

Screening and surveillance of esophageal varices: Validation of Baveno VI criteria in a cohort of cirrhotic HCV patients

Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis

P0206 : Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Increased plasma levels of Von Willebrand factor (VWF) and Factor VIII (FVIII) during acute bacterial infection drive a pro-hemostatic imbalance and herald severe outcome in cirrhosis

Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Safety and Effectiveness of anticoagulation in patients with cirrhosis listed for liver transplantation: a single center observational study

Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: really needed also in patients with HCV cured or HBV suppressed viral cirrhosis?

P.1.235: SERUM OSTEOPROTEGERIN IS DECREASED BY ANTI-TNF TREATMENT AND CORRELATES TO C-REACTIVE PROTEIN LEVELS

Risk factors for post-banding ulcer bleeding in cirrhotic patients undergoing elective esophageal varices band ligation

Preprocedural prophylaxis with blood products in patients with cirrhosis: results from a survey of the Italian Association for the study of the Liver (AISF)

THU-289 - Incidence and outcome of portal vein thrombosis in HCV cirrhotic patients treated with direct-acting antivirals: a single-center prospective 3-year study

Incidence and outcome of portal vein thrombosis in HCV cirrhotic patients treated with direct-acting antivirals: a single-center prospective 3-year study

FRI-350 - The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

The long-term risk and outcome of non-neoplastic portal vein thrombosis developing in compesated caucasian HBV cirrhotics treated with Tenofovir or Entecavir

Incidence of liver-related events in 647 HCV cirrhotics treated with DAA: A 5-year single center study

Suchergebnisse filtern